PharmaLundensis AB (XSAT:PHAL BTA) Buyback Yield % : -43.57 (As of Jul. 24, 2025)

View and export this data going back to . Start your Free Trial

What is PharmaLundensis AB Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

PharmaLundensis AB's current buyback yield was -43.57%.

PharmaLundensis AB Buyback Yield % Historical Data

The historical data trend for PharmaLundensis AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Buyback Yield % Chart

PharmaLundensis AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

PharmaLundensis AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buyback Yield %	Get a 7-Day Free Trial															-19.37	-12.32	-17.55	-12.75	-13.73

Competitive Comparison of PharmaLundensis AB's Buyback Yield %

For the Biotechnology subindustry, PharmaLundensis AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaLundensis AB's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

PharmaLundensis AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

PharmaLundensis AB's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-3.03	+	7.024)	/	0
	=	N/A%

PharmaLundensis AB's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (-3.31	+	9.847)		/	0
	=	N/A%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

PharmaLundensis AB Buyback Yield % Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL BTA) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

PHAL:Sweden

Address

PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines